About

Profound Medical Corp. (NASDAQ:PROF) is a commercial-stage medical technology company based in Mississauga, Ontario, advancing the standard of care for prostate cancer and BPH. Our proprietary, FDA-cleared technology, TULSA-PRO®, is the first and only AI-powered, MRI-guided, incision-free robotic ablation system for the ablation of prostate tissue. TULSA-PRO® gives physicians real-time precision and control, enabling customizable treatments that are both clinically effective and designed to preserve patients’ quality of life. Now available for maximum reimbursement. Discover the difference.